CLINICAL STUDY ON CEFPIROME

Cefpirome was administered intravenously to 16 patients with respiratory tract infections at 1-2 g b.i.d. for 4-15 days. Clinical efficacy was excellent in 3 cases, good in 11, poor in 1 and unknown in 1 case, the efficacy rate being 93.3%. No adverse reactions were observed.

Saved in:
Bibliographic Details
Published inCHEMOTHERAPY Vol. 39; no. Supplement1; pp. 531 - 535
Main Authors TAKEBE, KAZUO, MASUDA, MITSUO, MURAKAMI, SEIICHI, SAGARA, MORIO, OKAMOTO, KATSUHIRO, NAKAHATA, HISASHI, KAWAGISIH, TAKAHIKO, BOKU, AKITOSHI, GASA, KEIKO, MIYAZAWA, TADASHI, IMAMURA, KENICHI, TAMURA, TOYOKAZU, ENDO, KATSUMI, KIMURA, KENICHI
Format Journal Article
LanguageJapanese
Published Japanese Society of Chemotherapy 1991
Subjects
Cefpirome
Online AccessGet full text

Cover

More Information
Summary:Cefpirome was administered intravenously to 16 patients with respiratory tract infections at 1-2 g b.i.d. for 4-15 days. Clinical efficacy was excellent in 3 cases, good in 11, poor in 1 and unknown in 1 case, the efficacy rate being 93.3%. No adverse reactions were observed.
ISSN:0009-3165
1884-5894
DOI:10.11250/chemotherapy1953.39.Supplement1_531